High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer
Chaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, Hannah Marie Atkins, Hyesun Hyun, Yuseon Shin, Jacob D. Ramsey, Patrick D. Rädler, Kevin R. Mott, Charles M. Perou, Marina Sokolsky‐Papkov, Alexander V. Kabanov
Topics & Concepts
ChemoimmunotherapyTriple-negative breast cancerBreast cancerCancer researchTumor microenvironmentPaclitaxelImmune systemMetastasisChemistryCancerMedicineImmunologyImmunotherapyInternal medicineCancer Immunotherapy and BiomarkersImmune cells in cancerImmunotherapy and Immune Responses